Anti-tissue transglutaminase IgA antibodies in peripheral neuropathy and motor neuronopathy

Acta Neurologica Scandinavica

Volumn 114, Issue 1, 2006, Pages 54-58

  Mata S ^a   Renzi, D ^a   Pinto, F ^a   Calabro A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

ALS; Anti tissue transglutaminase antibodies; Celiac disease; Inflammatory polyneuropathy; Neuroimmunology; Peripheral neuropathies

Indexed keywords

GLYCOLIPID; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIGEN ANTIBODY REACTION; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PREVALENCE; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; COHORT STUDIES; FEMALE; GLYCOLIPIDS; HUMANS; IMMUNOGLOBULIN A; MALE; MASS SCREENING; MIDDLE AGED; MOTOR NEURON DISEASE; MOTOR NEURONS; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TRANSGLUTAMINASES;

EID: 33745049739     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00602.x     Document Type: Article

References (23)

1. Greenberg CS Birckbichler PJ Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991 5 : 3071 7.
2. Bruce SE Bjarnason I Peters TJ. Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci 1985 68 : 573 9.
3. Murray JA. The widening spectrum of celiac disease. Am J Clin Nutr 1999 69 : 354 65.
4. Dieterich W Ehnis T Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997 3 : 797 801.
5. Bizzaro N Villalta D Tonutti E et al. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci 2003 48 : 2360 5.
6. Picarelli A Di Tola M Sabbatella L et al. Anti-tissue transglutaminase antibodies in arthritic patients: a disease-specific finding Clin Chem 2003 49 : 2091 4.
7. Vecchi M Folli C Donato MF Formenti S Arosio E De Franchis R. High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Scand J Gastroenterol 2003 38 : 50 4.
8. Mirza A Liu SL Frizell E et al. A role for tissue transglutaminase in hepatic injury and fibrogenesis and its regulation by NF-kB. Am J Physiol 1997 272 : 281 8.
9. Johnson K Hashimoto S Lotz M Pritzker K Terkeltaub R. Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 2001 159 : 149 63.
10. Kim SY Grant P Lee JH Pant HC Steinert PM. Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. J Biol Chem 1999 274 : 30715 21.
11. Fujita K Honda M Hayashi R et al.. Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss. J Neurol Sci 1998 158 : 53 7.
12. Tetzlaff W Gilad VH Leonard C Bisby MA Gilad GM. Retrograde changes in transglutaminase activity after peripheral nerve injuries. Brain Res 1988 445 : 142 6.
13. Asbury AK Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990 27 : S21 4.
14. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial Clinical Limits of Amyotrophic Lateral Sclerosis Workshop Contributors. J Neurol Sci 1994 124 : 96 107.
15. Berger AR Bradley WG Brannagan TH et al. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2003 8 : 282 4.
16. England JD Gronseth GS Franklin G et al. Distal symmetrical polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005 64 : 199 207.
17. Mata S Betti E Masotti G Pinto F Lolli F. Motor nerve damage is associated with anti-ganglioside antibodies in diabetes. J Peripher Nerv Syst 2004 9 : 138 43.
18. Walker-Smith JA Guandalini S Schmitz J Shmerling DH Visakorpi JK. Revised criteria for diagnosis of celiac disease. Report of Working Group of European Society of Pediatric Gastroenterology and Nutrition. Arch Dis Child 1990 65 : 909 11.
19. Fabiani E Peruzzi E Mandolesi A et al. Anti-human vs anti-guinea pig tissue transglutaminase antibodies as the first-level serological screening test for coeliac disease in the general population. Dig Liver Dis 2004 36 : 671 6.
20. Villalta D Crovatto M Stella S Tonutti E Bozzoli R Bizzarro N. False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent. Clin Chim Acta 2005 256 : 102 9.
21. Willison HJ Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002 125 : 2591 625.
22. Alaedini A Green PH Sander HW et al. Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol 2002 127 : 145 8.
23. Mearin ML Ivarsson A Dickey W. Coeliac disease: is it time for mass screening Best Pract Res Clin Gastroenterol 2005 19 : 441 52.